Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03385486
Title Study of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhibitors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Taiga Biotechnologies, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
The Angeles Clinic and Research Institute RECRUITING Los Angeles California 90025 United States Details
University of Colorado Cancer Center RECRUITING Denver Colorado 80045 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field